Baltic Horizon Fondi 2024. aasta konsolideeritud auditeeritud finantstulemused
Northern Horizon Capital AS-i juhatus on kinnitanud Baltic Horizon Fondi (fond) 2024. aasta auditeeritud majandustulemused. Finantstulemused jäid samaks, võrreldes esialgse avalikustamisega 17. veebruaril 2025. Meie strateegilised püüdlused2024. aastal tegi Fondi…
Form 8.3 – AXA INVESTMENT MANAGERS: Advanced Medical Solutions Group plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…
Fantribe Inc. Announces Termination of Definitive Acquisition Agreement with Tritent International Corp.
MIAMI, March 28, 2025 (GLOBE NEWSWIRE) -- Fantribe, Inc. (the “Company”), a digital media platform connecting athletes, celebrities, and creators with their fans through immersive and monetizable experiences today announced…
Baltic Horizon Fund consolidated audited results for 2024
Management Board of Northern Horizon Capital AS has approved the unaudited financial results of Baltic Horizon Fund (the Fund) for the twelve months of 2024. The financial results remained unchanged…
Pactiv Evergreen Inc. Announces Receipt of All Required Regulatory Approvals for Planned Acquisition by Novolex
LAKE FOREST, Ill., March 28, 2025 (GLOBE NEWSWIRE) -- Pactiv Evergreen Inc. (“Pactiv Evergreen” or the “Company”) (NASDAQ: PTVE) today announced that all required regulatory approvals have been received in…
Disclosure of Voting Rights in IDEX Biometrics to Chair, Morten Opstad – 31 March 2025
At the close of business on 31 March 2025, Morten Opstad, chair of the board of IDEX Biometrics, held the following voting rights in IDEX, for the extraordinary general meeting…
Theriva™ Biologics anuncia resultados positivos de la segunda reunión del Comité independiente para la monitorización de los datos de VIRAGE, el ensayo clínico de Fase 2b de VCN-01 de la empresa en combinación con quimioterapia para el adenocarcinoma pancreático ductal metastásico
ROCKVILLE, Maryland, March 31, 2025 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), una empresa diversificada en fase clínica que desarrolla terapias diseñadas para tratar el cáncer y enfermedades relacionadas…
Curium 完成对 Monrol 的收购，其镥-177 产能及 PET 业务范围大幅扩大
确立了 Curium 的镥-177 同位素领先制造商地位为 Curium 注入创新的研发专业技术和产品管线拓展 Curium 的 SPECT 和 PET 地理覆盖范围和供应链 巴黎, March 29, 2025 (GLOBE NEWSWIRE) -- 全球核医学领域领导者 Curium Pharma (“Curium”) 宣布完成对 Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) 的收购，后者也是核医学领域的领先企业，总部位于土耳其伊斯坦布尔。…
Mulvihill Canadian Bank Enhanced Yield ETF Announces Year End Results
TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- (TSX: CBNK) Mulvihill Canadian Bank Enhanced Yield ETF (the “Fund”) announces results of operations for the year ended December 31, 2024. Increase in…
Premium Global Income Split Corp. Announces Year End Results
TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- (TSX: PGIC; PGIC.PR.A) Premium Global Income Split Corp. (the “Fund”) announces results of operations for the year ended December 31, 2024. Increase in…